SIRT2 and breast carcinoma: Interestingly, when McGlynn et al. investigated the correlation between SIRT2 expression levels in breast cancer and prognosis using IHC staining in 153 ER– and 392 ER+ breast cancer tissues, they observed more aggressive breast cancer phenotype with higher nuclear levels of SIRT2 (50).